Regulatory UpdatesAug 23, 2026•1 min read

Doncaster Pharma alerts MHRA over Braille embossing error on Hiprex 1 g tablets

By the PharmaCountry team

Doncaster Pharma reported a Braille embossing error on the outer packaging of certain parallel‑imported Hiprex 1 g tablets to the MHRA.

Doncaster Pharma Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of an error concerning the Braille embossing on the outer packaging of specific parallel‑imported batches of Hiprex 1 g tablets (prescription‑only medicine). The notification highlights a packaging issue that may affect accessibility for visually impaired users. No further details on the scope of the affected batches were provided.

Compiled by the PharmaCountry team · Source: MHRA

Topics:#Hiprex #Braille packaging #regulatory alert #Parallel import #MHRA